Litcius/Paper detail

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?

Mohammad Bahadoram, Bijan Keikhaei, Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani

2021Naunyn-Schmiedeberg s Archives of Pharmacology17 citationsDOIOpen Access PDF

Topics & Concepts

HydroxychloroquineInflammasomeChloroquineCytokine stormPathogenesisMedicineInflammationCoronavirus disease 2019 (COVID-19)PharmacologyImmunologyVirologyMalariaInternal medicineDiseaseInfectious disease (medical specialty)Inflammasome and immune disordersCOVID-19 Clinical Research StudiesVitamin C and Antioxidants Research
Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19? | Litcius